Top Markets
Coin of the day
HLB Pharmaceutical Co., Ltd HLB Pharmaceutical Co., Ltd

HLB Pharmaceutical Co., Ltd

047920
Classifica tra le azioni #19304
HLB Pharmaceutical Co., Ltd is a South Korean pharmaceutical firm dedicated to... HLB Pharmaceutical Co., Ltd is a South Korean pharmaceutical firm dedicated to the research and development of peptide-based drugs. Its product line encompasses a wide array of pharmaceutical preparations. These include medications for skeletal muscle relaxation, tranquilizing effects, antihistamine action, hypertension management, pain alleviation, anti-itching, astringent properties, anti-inflammatory relief, alimentary system support, metabolic regulation, ophthalmic conditions, local anesthesia, anti-arteriosclerosis, expectoration, fever reduction, analgesia, diabetes control, chemotherapy, peptic ulcer treatment, central nervous system issues, bacterial infections (antibiotics), digestive assistance, antacid needs, dental care, multivitamin supplementation, parasitic skin diseases, dermatological concerns, urogenital organ function, amino acid replacement, cough suppression, mucus thinning, parasitic worm elimination, diarrhea relief, circulatory system disorders, vitamin deficiencies, skin softening, hemorrhoid treatment, and liver ailments. Additionally, the company is actively developing CTT-004, an investigational therapy for ataxia associated with spinocerebellar degeneration, and offers Contract Manufacturing Organization (CMO) services. The enterprise, established in 1998, was formerly recognized as Mediforum Pharmaceutical Incorporation before adopting the name HLB Pharmaceutical Co., Ltd in October 2020. Its headquarters are located in Namyangju-Si, South Korea.
Prezzo delle azioni
$5.05
Capitalizzazione di mercato
$165.57M
Variazione (1 giorno)
-4.33%
Variazione (1 anno)
-48.19%
Paese
KR
Scambia HLB Pharmaceutical Co., Ltd (047920)

Categoria

Il prezzo 047920 con la capitalizzazione del mercato della B
HLB Pharmaceutical Co., Ltd HLB Pharmaceutical Co., Ltd
047920
$5.05
Capitalizzazione di mercato di HLB Pharmaceutical Co., Ltd(047920)
Capitalizzazione di mercato: $165.57M
A partire dal August 2026, HLB Pharmaceutical Co., Ltd ha una capitalizzazione di mercato pari a $165.57M. Questo rende HLB Pharmaceutical Co., Ltd la 19304th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di HLB Pharmaceutical Co., Ltd dal 2015 al 2026
047920 in paragone con la classifica dei più popolari stocks
Il prezzo per 047920 Attivo B Capitalizzazione del mercato a B Risultati
HLB Pharmaceutical Co., Ltd HLB Pharmaceutical Co., Ltd
$157,094 $165.57M
$5.152T +3,111,956.62%
HLB Pharmaceutical Co., Ltd HLB Pharmaceutical Co., Ltd
$138,329 $165.57M
$4.537T +2,740,220.38%
HLB Pharmaceutical Co., Ltd HLB Pharmaceutical Co., Ltd
$127,095 $165.57M
$4.169T +2,517,677.94%
HLB Pharmaceutical Co., Ltd HLB Pharmaceutical Co., Ltd
$111,051 $165.57M
$3.642T +2,199,847.39%
HLB Pharmaceutical Co., Ltd HLB Pharmaceutical Co., Ltd
$85,512.30 $165.57M
$2.805T +1,693,916.31%